Perceptive Advisors’s Scribe Therapeutics SCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCTX
BBA
Perceptive Advisors's SCTX Position: Q3 2026 in Review
Perceptive Advisors opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 920,341 shares worth $16.9M. The stake represents 0.3% of the portfolio and ranks #52 among its holdings.
62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.
- Perceptive Advisors held 920,341 shares of Scribe Therapeutics worth $16.9M as of Q3 2026.
- Scribe Therapeutics was a new Perceptive Advisors position in Q3 2026.
- Scribe Therapeutics made up 0.3% of Perceptive Advisors's portfolio in Q3 2026, its #52 holding.
- 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.
Based on Perceptive Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.